The obesity drug market swings between big wins and bigger doubts as new trial results, rising sales and treatment limits reshape the industry.
.jpg)
India’s pharma industry is looking beyond generics, but regulatory standards could determine how quickly it attracts global investment in innovation. Commerce and Industry Minister Piyush Goyal has called for greater alignment with developed...
Acquisitions and manufacturing steal the spotlight today as pharma companies pursue strategic deals, capacity expansion, and stronger market reach.
The global race to outpace cancer is accelerating, with MedGenome, HUTCHMED, AbbVie and Cipla advancing detection, treatment, survival and access.
Pharma companies are advancing critical care with innovative drugs, rare-disease research, and preventive diagnostics to address unmet needs.
India's cancer challenge is growing, while breakthrough therapies today offer new hope for patients through earlier detection and innovation.
Autoimmune therapies, oncology advances, and major takeovers take center stage as three significant biologics deals reshape industry pipelines today
This month brought several developments that shaped India's pharma industry, from new partnerships and licensing agreements to R&D expansion and international market opportunities
Regulatory actions from the USFDA and Maharashtra FDA dominated pharma news today. Companies secured key product approvals while others faced inspection findings and enforcement steps
The WHO science council has been renewed with 21 scientists and experts to help guide the future of global health. The World Health Organization announced the new membership.
.jpg)
, CDSCO.jpg)